51�Թ�

Finally, “biosurgery” got maggots out of the name, but they're still in the wounds.

Genzyme acquired nascent firms with products in cardiometabolic and renal diseases, biosurgery and hematologic oncology.

Atrium Medical, Getinge's biggest acquisition in four years, makes cardio-thoracic drainage products, vascular grafts, and biosurgery products, and is owned by a group of private investors.

Genzyme appears set to hold onto other non-core assets identified by analysts as potential divestiture targets, such as its biosurgery and renal businesses.

The lawsuit, amended in 2005, charged Genzyme's executives with deliberately driving down the value of Biosurgery's stock in order to buy it back at a price beneficial to Genzyme's shareholders but grossly unfair to Biosurgery shareholders.